Should We Be Concerned About Thyroid Cancer in Patients Taking Glucagon-Like Peptide 1 Receptor Agonists?

Cleveland Clinic Journal of Medicine - United States
doi 10.3949/ccjm.81a.13066
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Cleveland Clinic Journal of Medicine